Type I vs Type III Osteogenesis Imperfecta Differences

When a child is being evaluated for osteogenesis imperfecta (OI)—typically through X-rays and genetic testing—doctors often refer to the Sillence classification ^[1]. This system categorizes the condition into different types based on severity and symptoms. The two most commonly discussed types are Type I and Type III. While both affect how the body builds bone, they behave very differently in terms of severity, the underlying collagen defect, and how they impact a child’s daily life ^[1].

The Collagen Difference: Quantity vs. Quality

Collagen is the protein that acts like the scaffolding or framework for your bones. The main difference between Type I and Type III OI comes down to how this scaffolding is built.

• Type I (Not Enough Collagen): This is caused by a quantitative defect. The body’s collagen is perfectly normal in its structure, but it simply doesn’t produce enough of it—often only making about half the normal amount ^[1]. Because the collagen that is present is structurally sound, this is generally the mildest and most common form of OI ^[1].
• Type III (Malformed Collagen): This is caused by a qualitative defect. The body produces collagen, but the protein structure itself is abnormal and doesn’t form correctly ^[1]. Because the scaffolding itself is fundamentally flawed, bones are much more fragile and prone to bending ^[1].

How the Symptoms Differ

Because of the differences in how the collagen is made, the physical signs of Type I and Type III contrast significantly:

• When It Is Diagnosed: Because Type I is mild, parents may not even realize their child has the condition until they start standing, walking, or becoming more active, which is when the first fractures often happen. In contrast, Type III is typically diagnosed at birth or in early infancy because fractures frequently occur in the womb or during delivery ^[1].
• Fractures and Bone Shape: In Type I, children will experience fractures, but their bones generally heal straight, and significant long-bone or spinal curving is uncommon ^[1]. Type III is clinically described as a “progressively deforming” type. Children with Type III experience frequent fractures and progressive bone bowing (bending of the bones) ^[1]. However, modern orthopedic treatments and medications are specifically designed to help manage and minimize this bowing.
• Growth and Stature: Children with Type I generally grow to a normal or near-normal height ^[1]. Because of how the bone structure develops and heals in Type III, longitudinal growth is impacted, usually resulting in a shorter stature that is well below average ^[1].
• Sclerae (Whites of the Eyes): People with Type I OI often have distinctly blue or gray-tinted sclerae (the whites of the eyes) that persist throughout their lives ^[1]. The white part of the eye is thinner than normal, allowing the underlying tissue to show through. In Type III, the sclerae might be blue at birth but often fade to white or light gray as the child gets older ^[1].

Looking Ahead and Building a Care Team

Understanding the specific type of OI helps your care team anticipate your child’s needs. While a Type I diagnosis usually means focusing on safe activity and fracture management, a Type III diagnosis requires a more proactive, multidisciplinary team approach. This team typically includes medical geneticists, pediatric orthopedists, and specialized physical therapists.

For children with Type III, modern medical treatments have dramatically improved quality of life. Medical therapies—most notably bone-strengthening medications called bisphosphonates—are now a cornerstone of care that significantly improve survival and reduce fracture frequency ^[1]. Alongside medication, proactive orthopedic surgeries (like placing internal “rods” to straighten and protect bones) and regular monitoring of the spine help prevent respiratory complications as children grow ^[1][1]. With these advanced, coordinated treatments, children with Type III OI can lead highly fulfilling, joyful lives.